In vitro effect of relaxin in the rat corpus cavernosum under hyperglycemic and normoglycemic conditions
- 12 December 2022
- journal article
- research article
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 36 (1) , 72-77
Abstract
Relaxin, an endogenous peptide hormone, elicits vascular relaxation by its direct effect or by modulating the endothelium-dependent relaxation response and is clinically evaluated for the treatment of coronary artery disease. However, its effect on penile tissue has not been explored yet. This study aimed to investigate the effect of serelaxin, recombinant human relaxin-2, on rat corpus cavernosum (CC) under healthy and hyperglycemic conditions. Strips of CC obtained from thirty-nine male Wistar rats weighing 300–350 g were used in organ baths for isometric tension studies to investigate the serelaxin-mediated relaxation (10−12–10−7 M) under normoglycemic conditions and the effect of serelaxin on endothelium-dependent [nitric oxide (NO)- and prostacyclin-mediated] relaxation responses under hyperglycemic conditions. The in vitro hyperglycemia model was created by 3 h of incubation with 44 mM glucose monohydrate +120 μM methylglyoxal. NO-dependent relaxation responses were evaluated by cumulative acetylcholine (10−9–10−4 M) administration in the presence of indomethacin (10−6 M). Prostacyclin-mediated relaxation was evaluated by cumulative administration of iloprost (10−9–10−6 M), a prostacyclin analog. Maximum relaxation responses to serelaxin were not significantly different compared to the time-control (p = 0.480). Three hours of incubation of rat CC in hyperglycemic conditions impaired NO- and prostacyclin-mediated relaxation responses (p = 0.032 and p = 0.047, respectively). Serelaxin coincubation worsened NO-mediated relaxation responses (p = 0.016) but did not affect prostacyclin-mediated responses (p = 0.425). Together, our results demonstrate that in vitro administration of serelaxin does not cause relaxation in penile tissue and short-term in vitro serelaxin treatment in hyperglycemic conditions mimicked diabetes modulates endothelium-dependent responses by worsening NO-mediated responses. Serelaxin exerts different effects via different mechanism on endothelium-dependent responses depending on the dose and duration of exposure. Therefore, proper timing and dosing of serelaxin administration in the penile tissue need to be investigated in further studies in diabetic animal models.Keywords
This publication has 30 references indexed in Scilit:
- Effect of Relaxin on Human Sperm FunctionsJournal of Andrology, 2012
- Relaxin improves TNF-α-induced endothelial dysfunction: the role of glucocorticoid receptor and phosphatidylinositol 3-kinase signallingCardiovascular Research, 2012
- Relaxin Induces Rapid Dilation of Rodent Small Renal and Human Subcutaneous Arteries via PI3 Kinase and Nitric OxideEndocrinology, 2011
- RXFP1 Is Expressed on the Sperm Acrosome, and Relaxin Stimulates the Acrosomal Reaction of Human SpermatozoaAnnals of the New York Academy of Sciences, 2009
- Increased Endothelial Apoptotic Cell Density in Human Diabetic Erectile Tissue—Comparison with Clinical DataThe Journal of Sexual Medicine, 2009
- Relaxin Promotes Prostate Cancer ProgressionClinical Cancer Research, 2007
- Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscleBiochemical and Biophysical Research Communications, 1990
- Prostacyclin synthesis by the corpora cavernosa of the human penis: Evidence for muscarinic control and pathological implicationsProstaglandins, Leukotrienes and Medicine, 1986
- Metabolism of prostaglandins in human saphenous veinJournal of Surgical Research, 1983
- RELAXIN IN HUMAN SEMINAL PLASMA*Annals of the New York Academy of Sciences, 1982